Platelet Rich Plasma (PRP) for Vulvar Lichen Sclerosus
A Double Blind Placebo Controlled Trial of Autologous Platelet Rich Plasma (PRP) Intradermal Injections for the Treatment of Vulvar Lichen Sclerosus
Sponsor: Center for Vulvovaginal Disorders
A NA clinical study on Lichen Sclerosus of Vulva, this trial is completed. The trial is conducted by Center for Vulvovaginal Disorders and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Nov 2018 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 3 earlier versions
-
Sep 2018 — Nov 2018 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Center for Vulvovaginal Disorders
For direct contact, visit the study record on ClinicalTrials.gov .